June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 24, 2025

Exam Shift Spurs National Rights Battle

Democratic AGs push to relocate OB-GYN exams from Texas, citing threats to reproductive and gender-affirming care under state abortion bans.

KFF Health News

June 24, 2025

AAP Updates Adolescent Contraceptive Guidance

The American Academy of Pediatrics updates contraception guidelines for adolescents, emphasizing access, confidentiality, equity, and person-centered counseling.

Conexiant

June 24, 2025

Is T1b Diabetes Often Genetic?

A review of nearly 300 idiopathic diabetes cases found that about 30% of patients had undiagnosed genetic mutations, raising concerns about misclassification and underuse of comprehensive genetic testing.

Conexiant

June 18, 2025

PFAS Exposure Tied to Adolescent Hypertension

A new study found that prenatal exposure to specific PFAS compounds was associated with higher blood pressure in children and adolescents, with stronger effects observed in boys and Black children.

Conexiant

June 10, 2025

FDA Pledges Week-Long Drug Reviews

New leadership outlines accelerated approval processes, AI integration, and food additive restrictions to address the chronic disease epidemic

Conexiant

June 05, 2025

Risky College Behaviors Harming Oral Health?

First-year university students who adopted unhealthy habits such as poor diet, vaping, and reduced brushing frequency experienced significant declines in self-reported oral health over 6 months.

Conexiant

June 05, 2025

Can Adolescent Diets Predict Fatherhood?

New research shows fathers who improved their diet as teenagers were more likely to promote healthy eating in their children and had kids who ate more fruits and vegetables.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant